NO992916L - Fosfodiesterase 8A - Google Patents

Fosfodiesterase 8A

Info

Publication number
NO992916L
NO992916L NO992916A NO992916A NO992916L NO 992916 L NO992916 L NO 992916L NO 992916 A NO992916 A NO 992916A NO 992916 A NO992916 A NO 992916A NO 992916 L NO992916 L NO 992916L
Authority
NO
Norway
Prior art keywords
polypeptides
polynucleotides
pde8
expression constructs
phosphodiesterase
Prior art date
Application number
NO992916A
Other languages
English (en)
Norwegian (no)
Other versions
NO992916D0 (no
Inventor
Kate Loughney
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25491965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992916(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Icos Corp filed Critical Icos Corp
Publication of NO992916D0 publication Critical patent/NO992916D0/no
Publication of NO992916L publication Critical patent/NO992916L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO992916A 1997-10-16 1999-06-15 Fosfodiesterase 8A NO992916L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/951,648 US5932465A (en) 1997-10-16 1997-10-16 Phosphodiesterase 8A
PCT/US1998/021956 WO1999019495A1 (en) 1997-10-16 1998-10-16 Phosphodiesterase 8a

Publications (2)

Publication Number Publication Date
NO992916D0 NO992916D0 (no) 1999-06-15
NO992916L true NO992916L (no) 1999-08-06

Family

ID=25491965

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992916A NO992916L (no) 1997-10-16 1999-06-15 Fosfodiesterase 8A

Country Status (14)

Country Link
US (4) US5932465A (de)
EP (2) EP1571216A3 (de)
JP (1) JP2001512327A (de)
CN (2) CN1800399A (de)
AT (1) ATE295423T1 (de)
AU (1) AU1097499A (de)
BR (1) BR9806318A (de)
CA (1) CA2275135A1 (de)
DE (1) DE69830143T2 (de)
ES (1) ES2245485T3 (de)
IL (3) IL130287A0 (de)
NO (1) NO992916L (de)
RU (2) RU2272841C2 (de)
WO (1) WO1999019495A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238283C (en) 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
EP0967284A1 (de) * 1998-05-28 1999-12-29 Pfizer Limited Phosphodiesterasen
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
GB9922125D0 (en) 1999-09-17 1999-11-17 Pfizer Ltd Phosphodiesterase enzymes
US6673564B2 (en) * 1999-10-18 2004-01-06 Millennium Pharmaceuticals, Inc. Methods for using 22045, a human cyclic nucleotide phosphodiesterase
CN1297049A (zh) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人环磷酸鸟嘌呤抑制的磷酸二酯酶17和编码这种多肽的多核苷酸
US6555547B1 (en) 2000-02-28 2003-04-29 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en) 2000-03-03 2003-05-27 Cell Pathways, Inc Method for screening compounds for the treatment of neoplasia
CN1312381A (zh) * 2000-03-07 2001-09-12 上海博德基因开发有限公司 一种新的多肽——人环腺苷酸磷酸二脂酶13和编码这种多肽的多核苷酸
ATE373717T1 (de) * 2000-09-12 2007-10-15 Univ Washington Pde8a und seine verwendung
IL159722A0 (en) * 2001-07-10 2004-06-20 Oligos Etc Inc Pharmaceutical compositions containing oligonucleotides
WO2004042388A2 (en) * 2002-11-08 2004-05-21 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a)
AU2005223847A1 (en) 2004-03-19 2005-09-29 Yale University Detection, isolation and uses of renalase (Monoamine Oxidase C)
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2630085A1 (en) 2005-11-21 2007-05-24 Yale University Methods of regulating renalase (monoamine oxidase c)
AU2008230710B2 (en) * 2007-03-27 2014-04-10 Omeros Corporation The use of PDE7 inhibitors for the treatment of movement disorders
JP6148007B2 (ja) * 2009-05-12 2017-06-14 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７
SG193024A1 (en) * 2011-03-11 2013-10-30 Synageva Biopharma Corp Npp1 fusion proteins
RU2760943C2 (ru) * 2011-09-15 2021-12-01 Алексион Фармасьютикалз, Инк. Гибридные белки NPP1
EP2804603A1 (de) 2012-01-10 2014-11-26 President and Fellows of Harvard College Betazellen-replikation für promoterverbindungen und verwendungsverfahren dafür

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3501286B2 (ja) * 1989-12-22 2004-03-02 アプライド リサーチ システムズ，エーアールエス ホールディング ナームロゼ ベノートスハップ 一定の細胞系又は微生物の内因性遺伝子の発現特徴の変性のための方法
EP0539573A4 (en) * 1991-05-15 1993-12-29 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5798246A (en) * 1996-03-25 1998-08-25 Incyte Pharmaceuticals, Inc. Cyclic nucleotide phosphodiesterase

Also Published As

Publication number Publication date
EP1571216A2 (de) 2005-09-07
EP0944725B1 (de) 2005-05-11
AU1097499A (en) 1999-05-03
EP1571216A3 (de) 2006-04-26
IL175698A0 (en) 2008-02-09
DE69830143D1 (en) 2005-06-16
JP2001512327A (ja) 2001-08-21
ES2245485T3 (es) 2006-01-01
US6133007A (en) 2000-10-17
US20030215919A1 (en) 2003-11-20
CN1229499C (zh) 2005-11-30
NO992916D0 (no) 1999-06-15
ATE295423T1 (de) 2005-05-15
EP0944725A1 (de) 1999-09-29
CA2275135A1 (en) 1999-04-22
WO1999019495A1 (en) 1999-04-22
RU2005136013A (ru) 2007-05-27
CN1248291A (zh) 2000-03-22
RU2272841C2 (ru) 2006-03-27
DE69830143T2 (de) 2006-03-02
US5932465A (en) 1999-08-03
IL130287A0 (en) 2000-06-01
US6566087B1 (en) 2003-05-20
IL130287A (en) 2006-08-20
BR9806318A (pt) 2000-03-14
CN1800399A (zh) 2006-07-12

Similar Documents

Publication Publication Date Title
IL175698A0 (en) Phosphodiesterase 8a
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
DE69805237D1 (de) Tumornekrose zugehöriger Rezeptor, TR4
ATE331791T1 (de) Phosphodiesterase 10
WO2000029574A3 (en) Inflammation-associated genes
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
WO1999033870A3 (en) Human regulatory proteins
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
NO990666D0 (no) FremgangsmÕte for diversitets-kombinering, samt mottaker
WO2001007471A3 (en) Cell cycle and proliferation proteins
WO2000021986A3 (en) Matrix-remodeling genes
WO1999009182A3 (en) Rab proteins
WO2000040722A3 (en) Insulin-synthesis genes
PE20399A1 (es) Muteina ob
WO2000001821A3 (en) Neurotransmission associated proteins
WO1998057986A3 (en) Human preprotachykinin b
WO1999029720A3 (en) Mammalian alpha helical protein-1
WO2000060082A3 (en) Vesicle associated proteins
WO2001004297A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2000071679A3 (en) Human oxidoreductase proteins
WO2000052161A3 (en) Leukocyte- and blood-associated proteins
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
WO1999043829A3 (en) Cell cycle related proteins
WO2000014248A8 (en) Cyclic nucleotide-associated proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application